On this page

Priorix

Measles, Mumps and Rubella Vaccine Live

351(a) Standalone BLA

Overview

Source: Purple Book

Proprietary name

Priorix

Proper name

Measles, Mumps and Rubella Vaccine Live

Licence type

351(a)

BLA number

125748

Applicant

GlaxoSmithKline Biologicals

Center

CBER

Presentations

First licensure

—

Source: Purple Book

Every strength and presentation recorded in the Purple Book for this product.
Strength	Dosage form	Route	Presentation	Status	Licensed
3.4, 4.2 and 3.3LOG10	For Injection	Subcutaneous	Single-Dose Vial	Rx	June 3, 2022

Purple Book	FDA	Licence type, presentations, reference product, exclusivity